Construction of engineered cardiac tissue on a heart-on-a-chip device enables modeling of arrhythmogenic right ventricular cardiomyopathy
Biosensors and Bioelectronics · 2025
DOI: 10.1016/j.bios.2025.117478 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2025. Verfasst von Kai-Yun Qu und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing, 210096, Chi…. Hauptthemen laut MEDLINE: Arrhythmogenic Right Ventricular Dysplasia, Tissue Engineering, Myocytes, Cardiac, Lab-On-A-Chip Devices. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangsu Province Natural Science Foundation.
Abstract (Originalsprache)
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a progressive cardiac disorder characterized by the replacement of the right ventricular myocardium with fibrofatty tissue, with an incidence rate of approximately 1 in 5000. To advance our understanding of its pathology and facilitate drug screening, there is an urgent need for myocardial models that closely replicate human physiological conditions. In this study, we developed an engineered cardiac tissue (ECT) model on a chip using cardiomyocytes differentiated from induced pluripotent stem cells (iPSCs) derived from ARVC patients. The disease ECT model successfully recapitulated key phenotypic features of ARVC, including reduced contractility, arrhythmic events, and abnormal calcium transients. We further assessed the drug responses of the model to isoproterenol and amiodarone, confirming increased sensitivity to isoproterenol in the ARVC model, while amiodarone effectively alleviated the arrhythmic events. In conclusion, our ECT model successfully reproduced ARVC phenotypes, providing a novel platform for drug screening and pathological studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing, 210096, China.
- Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, 210029, China.
- State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing, 210096, China; Department of Cardiology, The First Affiliated Hospital with Nanji…
- Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, 210029, China. Electronic address: cuichang@njmu.edu.cn.
- Department of Cardiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, 210029, China. Electronic address: zhangfeng@njmu.edu.cn.
- State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing, 210096, China. Electronic address: nphuang@seu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Jiangsu Province Natural Science Foundation
Zitieren
APA
Qu, K. Y., Cheng, H. Y., Qiao, L., Jiao, J. C., Chang, S. Q., Peng, X. F., Cui, C., Zhang, F., & Huang, N. P. (2025). Construction of engineered cardiac tissue on a heart-on-a-chip device enables modeling of arrhythmogenic right ventricular cardiomyopathy. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2025.117478
Vancouver
Qu KY, Cheng HY, Qiao L, Jiao JC, Chang SQ, Peng XF, et al. Construction of engineered cardiac tissue on a heart-on-a-chip device enables modeling of arrhythmogenic right ventricular cardiomyopathy. Biosensors and Bioelectronics. 2025. doi:10.1016/j.bios.2025.117478
BibTeX
@article{Qu2025,
author = {Qu, Kai-Yun and Cheng, Hong-Yi and Qiao, Li and Jiao, Jin-Cheng and Chang, Shi-Qi and Peng, Xia-Feng and Cui, Chang and Zhang, Feng and Huang, Ning-Ping},
title = {Construction of engineered cardiac tissue on a heart-on-a-chip device enables modeling of arrhythmogenic right ventricular cardiomyopathy},
journal = {Biosensors and Bioelectronics},
year = {2025},
doi = {10.1016/j.bios.2025.117478}
}
EUVIMED